José M Añón
José M Añón is an expert in Critical care at Hospital Universitario La Paz (Spain). As of October 2026, ScienceLeadR ranks José M Añón in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. José M Añón has authored 128 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 3 of them ongoing. SLR score: 560 (community average: 125). How the SLR is computed.
LeadR Profile
Critical care
Subspecialties: Pulmonology - Public Health - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 128
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Perceived sustainability and alternatives to the on-call model in intensive care medicine: A survey of intensivists in the Community of Madrid. PMID 42934034 | Med Intensiva (Engl Ed) | 2026 | 0 |
| The author replies. PMID 42709605 — intensive care units | Crit Care Med | 2026 | 0 |
| Tracheostomy decannulation: adapting the evidence to regional healthcare factors. PMID 41896085 — tracheostomy | Med Intensiva (Engl Ed) | 2026 | 0 |
| Fiberoptic Bronchoscopy Monitoring During Percutaneous Dilatational Tracheostomy: A Multicenter, Randomized, Controlled Trial. The FIBERTRACH Randomized Clinical Trial. PMID 41757863 — tracheostomy, bronchoscopy, prevalence, intensive care units | Crit Care Med | 2026 | 0 |
| Rare genetic variant risks in patients with sepsis-associated acute respiratory distress syndrome. PMID 41736087 — respiratory physiological phenomena, sepsis, respiratory distress syndrome | Respir Res | 2026 | 1 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Inhaled sedation in the critically ill patient 2024-518521-14-00 — critical illness, ventilation | Phase 4 | Recruiting | 2025 |
| Inhaled Sedation in Critically Ill Patients NCT07000526 — airway extubation, delirium, propofol, critical illness, isoflurane, ventilation | Phase 4 | Recruiting | 2025 |
| Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions NCT04545242 — dexamethasone, respiratory insufficiency, covid-19, calcium, calcium dobesilate, ventilation, infections | Phase 4 | Recruiting | 2021 |
LeadR Networks
Main global connection map